Pharmaids Pharmaceuticals Quarterly Results for Trading Insights
In Sept 2025, Pharmaids Pharmaceuticals (PHARMAID) reported revenue ₹12 Cr and net profit ₹-3 Cr — revenue +140.0% YoY. For annual financials, live price and key ratios, visit Pharmaids Pharmaceuticals share price screener.
PHARMAID Quarterly Results — Revenue, Profit & EPS Highlights
Pharmaids Pharmaceuticals latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with Pharmaids Pharmaceuticals valuation methods to assess whether the stock is under or overvalued.
- Revenue of ₹12 Cr in Sept 2025 (+140.0% vs Mar 2025, +140.0% vs Sept 2024)
- Net Profit of ₹-3 Cr in Sept 2025 (+40.0% vs Mar 2025, -50.0% vs Sept 2024)
- EBITDA of ₹-2 Cr in Sept 2025 (+50.0% vs Mar 2025)
- Operating Margin of -62.0% in Sept 2025 (+20.0pp vs Mar 2025)
- Earnings Per Share of ₹-0.70 in Sept 2025 (+36.9% vs Mar 2025)
Pharmaids Pharmaceuticals Quarterly Results — Revenue, EBITDA, Net Profit & EPS
PHARMAID quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 12 | 5 | 7 | 6 | 5 | 140.0% | 140.0% |
| Net Profit (₹ Cr) | -3 | -5 | -5 | -3 | -2 | - | - |
| EBITDA (₹ Cr) | -2 | -4 | -5 | -3 | -2 | - | - |
| EPS (₹) | -0.70 | -1.11 | -1.39 | -0.70 | -0.73 | - | - |
| Operating Margin (%) | -62.0% | -82.0% | -81.0% | -53.0% | -46.0% | - | - |
PHARMAID Share Price Trend — 1-Year Movement Across Quarterly Results
Pharmaids Pharmaceuticals 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore PHARMAID stock price history to track price trends across different timeframes.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
PHARMAID vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Pharmaids Pharmaceuticals latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹415,924.72 Cr | 1808.3 | 14,875 | 3,125 | +10.8% | - | 21.0% | 139.1 |
|
Divis Laboratories
Sept 2025 |
₹171,625.44 Cr | 6502.5 | 2,860 | 689 | +7.1% | - | 24.1% | 250.4 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹142,059.09 Cr | 4185.1 | 3,219 | 591 | +11.3% | - | 18.4% | 238.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,348.15 Cr | 1322.9 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.8 |
|
Cipla
Sept 2025 |
₹105,996.98 Cr | 1309.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 78.3 |
All amounts in ₹ Crores